LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Are there clinical factors that can predict prolonged survival of patients receiving olaparib as maintenance therapy for BRCA-mutated ovarian cancer?

Photo from wikipedia

Ovarian cancer is highly prevalent and the second most deadly gynecological cancer (1). It is estimated that globally in the year 2018 there were 295,414 new cases and 184,799 deaths… Click to show full abstract

Ovarian cancer is highly prevalent and the second most deadly gynecological cancer (1). It is estimated that globally in the year 2018 there were 295,414 new cases and 184,799 deaths because of this disease. Epithelial ovarian carcinomas account for 85% to 90% of all malignant ovarian cancers, and more than half of those are the histotype serous carcinoma (2).

Keywords: clinical factors; prolonged survival; ovarian cancer; cancer; predict prolonged; factors predict

Journal Title: Translational cancer research
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.